Jacqueline G. O'Leary, Henry Randall, Nicholas Onaca, Linda Jennings, Göran B. Klintmalm, Gary L. Davis – 26 March 2009 – Outcomes after orthotopic liver transplantation for chronic hepatitis C have been reported to be worsening over the last 2 decades. We analyzed our center's experience over 15 years to identify trends in post–orthotopic liver transplantation survival in patients with and without hepatitis C virus infection.

Lena Thin, Gerry MacQuillan, Leon Adams, George Garas, Cynthia Seow, Paul Cannell, Bradley Augustson, Andrew Mitchell, Luc Delriveire, Gary Jeffrey – 26 March 2009 – Acute graft‐versus‐host disease following orthotopic liver transplantation is a rare but feared complication arising in 1% to 2% of cases with a dismal prognosis. It most often presents as fever, rash, and diarrhea with or without pancytopenia. Patients die from complications of marrow failure such as sepsis or bleeding. Because of its low incidence, there is no clear treatment protocol for this complication.

Marco Casaccia, Gabriele Barabino, Enzo Andorno, Maurizio Nicorelli, Elisa Porcile, Maximiliano Gelli, Pietro Diviacco, Umberto Valente – 26 March 2009

Joos Heisterkamp, Geert Kazemier – 26 March 2009

Shin Hwang, Sung‐Gyu Lee, Chul‐Soo Ahn, Ki‐Hun Kim, Deok‐Bog Moon, Tae‐Yong Ha, Gi‐Won Song, Dong‐Hwan Jung, Je‐Ho Ryu, Kyung‐Hoon Ko, Nam‐Kyu Choi, Kwan‐Woo Kim – 26 March 2009 – This study was intended to describe in detail the surgical technique and long‐term outcome of autologous portal vein (PV) Y‐graft interposition for adult living donor liver transplantation (LDLT). We assessed the outcome of 841 patients who underwent right lobe LDLT from January 2002 to December 2007 with respect to the reconstruction of double‐graft PVs.

Dmitriy Nikitin, Linda W. Jennings, Tariq Khan, Sugam Vasani, Richard Ruiz, Edmund Q. Sanchez, Srinath Chinnakotla, Marlon F. Levy, Robert M. Goldstein, Goran B. Klintmalm – 26 March 2009 – Portal vein problems remain a formidable challenge in liver transplantation. In select situations, a portal vein conduit can provide a solution. No long‐term results have been reported.

Feng Li, Kristin L. Mekeel, Mackam Eleid, M.E. Harrison, K. Sudhakar Reddy, Adyr A. Moss, David C. Mulligan – 25 February 2009

Jenny O. Smith, Mitchell L. Shiffman, Martha Behnke, R. Todd Stravitz, Velimir A. Luketic, Arun J. Sanyal, Doug M. Heuman, Robert A. Fisher, Adrian H. Cotterell, Daniel G. Maluf, Marc P. Posner, Richard K. Sterling – 25 February 2009 – Orthotopic liver transplantation (OLT) is the only effective treatment for end‐stage liver disease. Although most patients do well and are discharged promptly, some require prolonged length of stay (PLOS). The prevalence of PLOS, associated factors, and their impact on survival are not well defined.

Reto Eggenschwiler, Tobias Cantz – 25 February 2009

25 February 2009